Post10 Sep at 2:22 pmMureva Announces FDA De Novo Authorization and Peer-Reviewed Publication of Pivotal Mureva OM TrialPress ReleaseAbby Clark
PostOctober 3, 2023MuReva Phototherapy presents data from pilot study of Head and Neck Cancer Patients Treated Daily with an Intraoral Photobiomodulation (PBM) Device during the ASTRO 2023 Annual MeetingNewsLarry Yost
PostDecember 16, 2025American Medical Association Establishes Category III CPT Code for Procedure Associated with the Use of MuReva Phototherapy’s LED-based Photobiomodulation Therapy DevicePress ReleaseLarry Yost
PostOctober 28, 2025MuReva Phototherapy Presents Data during 2025 ASTRO Meeting Confirming Safety and Efficacy of the Company’s LED-based Photobiomodulation Therapy DevicePress ReleaseLarry Yost
